258 related articles for article (PubMed ID: 10629564)
1. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
[TBL] [Abstract][Full Text] [Related]
2. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
3. [The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts].
Qiao C; Cheng DL; Zhang SL; Wang CH; Lin QD
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):839-42. PubMed ID: 15949403
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
5. [Expression of TM4SF9 in human trophoblasts].
Gao TY; Yu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
[TBL] [Abstract][Full Text] [Related]
6. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
8. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
Pongcharoen S; Searle RF; Bulmer JN
Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
[TBL] [Abstract][Full Text] [Related]
10. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
11. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease].
Ding F; Zhang QS; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):150-2. PubMed ID: 17355922
[TBL] [Abstract][Full Text] [Related]
12. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
13. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
14. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen and related molecules in normal and transformed trophoblast.
Vićovac Lj; Bozić M; Bojić-Trbojević Z; Golubović S
Placenta; 2007; 28(2-3):85-96. PubMed ID: 16574224
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma expression in normal human placenta, hydatidiform mole and choriocarcinoma.
Capparuccia L; Marzioni D; Giordano A; Fazioli F; De Nictolis M; Busso N; Todros T; Castellucci M
Mol Hum Reprod; 2002 Jun; 8(6):574-9. PubMed ID: 12029076
[TBL] [Abstract][Full Text] [Related]
17. Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness.
Miko E; Halasz M; Jericevic-Mulac B; Wicherek L; Arck P; Arató G; Skret Magierlo J; Rukavina D; Szekeres-Bartho J
J Reprod Immunol; 2011 Jun; 90(1):50-7. PubMed ID: 21632119
[TBL] [Abstract][Full Text] [Related]
18. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
Shih IM; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
[TBL] [Abstract][Full Text] [Related]
19. Decorin and biglycan immunolocalization in non-villous structures of healthy and pathological human placentas.
Borbely AU; Daher S; Ishigai MM; Mattar R; Sun SY; Knöfler M; Bevilacqua E; Oliveira SF
Histopathology; 2014 Apr; 64(5):616-25. PubMed ID: 24117774
[TBL] [Abstract][Full Text] [Related]
20. Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes.
Bansal R; Kumar M; Murray K; Pfeiffer SE
Mol Cell Neurosci; 1996 Apr; 7(4):276-88. PubMed ID: 8793863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
